Alumis (ALMS) Other Accumulated Expenses (2023 - 2025)

Alumis (ALMS) reported Other Accumulated Expenses of $22.3 million for Q4 2025, up 14015.82% year-over-year from N/an in Q4 2024, and up 35301.59% on a QoQ basis from $63000.0 in Q3 2025.

Alumis (ALMS) has 3 years of Other Accumulated Expenses data on file, last reported at $22.3 million in Q4 2025.

  • Quarterly Other Accumulated Expenses rose 14015.82% year-over-year to $22.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.3 million (up 14015.82% YoY) and the FY2025 annual result came in at $22.3 million, up 14015.82% from the prior year.
  • Other Accumulated Expenses climbed to $22.3 million in Q4 2025 per ALMS's latest filing, from $63000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $22.8 million in Q2 2025 and bottomed at $63000.0 in Q3 2025.
  • The 3-year median for Other Accumulated Expenses is $7.6 million (2023), against an average of $9.5 million.
  • The widest annual swing landed in 2024, when Other Accumulated Expenses tumbled 97.77%; it then surged 14015.82% in 2025.
  • Tracing ALMS's Other Accumulated Expenses over 3 years: stood at $7.1 million in 2023, then plunged by 97.77% to $158000.0 in 2024, then surged by 14015.82% to $22.3 million in 2025.
  • Per Business Quant, the three latest ALMS Other Accumulated Expenses figures stand at $22.3 million (Q4 2025), $63000.0 (Q3 2025), and $22.8 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Alumis 1.84 Bn 1.75 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 22.30 Mn
Sep 30, 2025 63,000.00
Jun 30, 2025 22.81 Mn
Mar 31, 2025 15.73 Mn
Dec 31, 2024 158,000.00
Sep 30, 2024 77,000.00
Jun 30, 2024 8.12 Mn
Dec 31, 2023 7.09 Mn